The US Food and Drug Administration will now review Moderna's influenza vaccine. This comes after an initial refusal due to trial design is...

US Health Secretary Robert F. Kennedy Jr. stopped 22 vaccine projects. These projects used mRNA technology. The vaccines aimed to fight COV...

The US Department of Health and Human Services has planned to cancel $500 million in funding for mRNA vaccines, citing potential risks and ...

Moderna is set to reduce its global workforce by roughly 10%, aiming for under 5,000 employees by year's end, as it accelerates cost-cuttin...

Moderna had said earlier this year it expects operating costs to be between $4.7 billion and $5 billion for 2027. MRNA stock, which has los...

The Trump administration has slashed $766 million allocated in funding to Moderna Inc., an American biotech and pharmaceutical company resp...

Moderna has withdrawn its application for a combination flu and COVID vaccine, awaiting efficacy data from a late-stage influenza shot tria...

The H5N1 virus is common in wild birds and other animals. While it has not conclusively been found to spread from person to person, the amo...

The pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly durin...

Sanofi and Novavax partnered for a COVID-19 vaccine deal. Novavax will receive $1.2 billion in milestones. Sanofi will take an equity stake...

Moderna, the COVID-19 vaccine manufacturer, is poised to meet its 2023 sales target as it taps into the private market. Analysts suggest th...

Data from the second trial comes two months after its flu vaccine generated a strong immune response against influenza A strains, but was i...

Flu shots cost around $18 to $25 a dose, according to U.S. government data and competition has kept price increases in check, with producer...

Moderna's announcement comes after pharmaceutical giant Pfizer Inc. said its COVID-19 vaccine remained effective months after the second do...

The new technology was not only lightning fast but also incredibly effective - mRNA Covid vaccines from both Moderna and Pfizer hit the bul...

The makers of COVID-19 vaccines are figuring out how to tweak their recipes against worrisome virus mutations - and regulators are looking ...

On Monday, an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions...